Acquisition - November 2, 2015
Karo Bio acquires over 90% of MedCore
Karo Bio acquires more than 90 percent of the shares in MedCore AB, a company which primarily markets licensed medtech products to pharmacies and hospitals in the Nordic region. MedCore’s products target the therapeutic areas Diabetes, Anesthesia/Intensive Care and Surgery. Turnover is approx. MSEK 50 with an operating profit expected to be slightly positive in 2015. […]
Acquisition - November 1, 2015
AstraZeneca acquires ZS Pharma
AstraZeneca has entered into a definitive agreement to acquire ZS Pharma, a biopharmaceutical company based in San Mateo, California. ZS Pharma uses its proprietary ion-trap technology to develop novel treatments for hyperkalaemia (high potassium levels), a serious condition of elevated potassium in the bloodstream, typically associated with chronic kidney disease (CKD) and chronic heart failure […]
Acquisition - October 29, 2015
Probi signs deal with Seoul Milk for probiotic strains
Swedish Probi has signed a deal with Korean Seoul Milk to include probiotic strains in their dairy products. The biotech company Probi signs a licensing and supply deal with the Korean dairy producer Seoul Milk. This is the first time Probi signs a deal for probiotic dairy products. Probi’s probiotic strain LP299V will be included […]
Acquisition - October 5, 2015
Karo Bio acquires Swereco Group
Karo Bio AB has acquired the shares in Swereco Group. Swereco markets OTC products mainly to pharmacies or directly to health care providers. Net sales in 2014 were 150 MSEK. There are several well-established brands in the product portfolio. Mabs medical compression stockings have a leading market position in Sweden and accounts for over 40 […]
Acquisition - October 5, 2015
Recipharm acquires Nitin Lifesciences
The Swedish CDMO company will acquire majority stake in the Indian Nitin Lifesciences, a sterile injectables CMO, currently owned by the Sobti family. Recipharm will acquire 74 percent of the shares for an estimated purchase consideration of INR 6,712 million (SEK 872 million) on a cash and debt free basis. Recipharm will join forces with […]
Acquisition - October 2, 2015
Sectra acquires EXP Analytics
The IT and Medical Technology company Sectra has acquired the Finnish consulting company, EXP Analytics. EXP Analytics specializes in conducting analyses, as well as preparing strategies and solutions for information and cyber security on behalf of public authorities in Finland. The company has six employees and annual sales amount to approximately EUR 1 million. The acquisition […]
